Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy
- PMID: 28522344
- DOI: 10.1016/j.bbmt.2017.05.013
Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy
Abstract
Hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) is a severe complication whose pathophysiology is unknown. We describe 6 patients in which the disease was associated with complement regulatory gene abnormalities received from their respective donors. It is suggested that mutated and transplanted monocyte-derived cells are responsible for production of abnormal proteins, complement dysregulation, and, ultimately, for the disease. This observation might have important drawbacks as far as HSCT-TMA pathophysiology and treatment are concerned.
Keywords: Complement; Complement gene mutations; Hematopoietic stem cell transplantation (HSCT); Hemolytic uremic syndrome; Thrombotic microangiopathy (TMA).
Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Unraveling the Genetics of Transplant-Associated Thrombotic Microangiopathy: Lessons to be Learned.Biol Blood Marrow Transplant. 2017 Nov;23(11):2013-2014. doi: 10.1016/j.bbmt.2017.07.018. Epub 2017 Jul 26. Biol Blood Marrow Transplant. 2017. PMID: 28756242 No abstract available.
-
Response.Biol Blood Marrow Transplant. 2017 Nov;23(11):2014-2015. doi: 10.1016/j.bbmt.2017.07.017. Epub 2017 Aug 15. Biol Blood Marrow Transplant. 2017. PMID: 28821453 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
